1990
DOI: 10.1016/0378-5173(90)90268-9
|View full text |Cite
|
Sign up to set email alerts
|

Development of biphasic transdermal nitroglycerin delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2001
2001

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…In addition, since the active ingredient moves with the blood stream directly into the targeted organ, the effective dose can be lower than that in the traditional drug types 3–5. Several forms of TTSs have been developed in recent years,6–8 which may be divided into two major groups: In the first case, the optimal degree of release of the active ingredient is provided by the plaster base and the plaster structure together and, in the second case, by a special microporous or nonporous membrane. In our previous work,2 the objective was to select silicon rubber base materials that will allow the development of a new TTS with optimal characteristics.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, since the active ingredient moves with the blood stream directly into the targeted organ, the effective dose can be lower than that in the traditional drug types 3–5. Several forms of TTSs have been developed in recent years,6–8 which may be divided into two major groups: In the first case, the optimal degree of release of the active ingredient is provided by the plaster base and the plaster structure together and, in the second case, by a special microporous or nonporous membrane. In our previous work,2 the objective was to select silicon rubber base materials that will allow the development of a new TTS with optimal characteristics.…”
Section: Resultsmentioning
confidence: 99%